Advertisement
Research Article| Volume 19, ISSUE 1, P169-186, March 1999

Download started.

Ok

Acute Lymphoblastic Leukemia

  • Steven J. Melnick
    Correspondence
    Address reprint requests to: Steven J. Melnick, PhD, MD, Department of Pathology, Miami Children’s Hospital, 3100 S.W. 62nd Avenue, Miami, FL 33155.
    Affiliations
    From the Department of Pathology and Laboratories, Miami Children’s Hospital, Miami, Florida
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30134-3
Acute Lymphoblastic Leukemia
Previous ArticleTransient Myeloproliferative Disorder (Transient Leukemia) and Hematologic Manifestations of Down Syndrome
Next ArticleDiagnosis of Childhood Acute Myeloid Leukemia
      This paper is only available as a PDF. To read, Please Download here.
      This article reviews the laboratory methodologies used to evaluate acute lymphoblastic leukemia (ALL) in children and their role in establishing a diagnosis and prognosis of this disease. These methodologies are: morphology, flow cytometry, cytogenetics, and molecular diagnostics. Additionally, immunophenotypic classifications of ALL and criteria for establishing a diagnosis of ALL independent of morphology are described.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Bene M.C.
        • Castoldi G.
        • Knapp W.D.
        • et al.
        Proposals for the immunological classification of acute leukemias.
        Leukemia. 1995; 9: 1783
        • Bennett J.M.
        • Catovsky D.
        • Daniel M.T.
        • et al.
        The morphological classification of acute lymphoblastic leukemia: Concordance among observers and clinical correlations.
        Br J Haematol. 1981; 47: 553
        • Bertoli L.F.
        • Burrows P.D.
        Normal B-lineage cells: Their differentiation and identification.
        Clin Lab Med. 1988; 8: 15
        • Borowitz M.J.
        • Bray R.
        • Gascoyne R.
        • et al.
        U.S.-Canadian Consensus Recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation.
        Cytometry. 1997; 30: 236
        • Borowitz M.J.
        • Guenther K.L.
        • Shults K.E.
        • et al.
        Immunophenotyping of acute leukemia by flow cytometric analysis: Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis.
        Am J Clin Pathol. 1993; 100: 534
        • Borowitz M.J.
        • Hunger S.P.
        • Carroll A.J.
        • et al.
        Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: Implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: A Pediatric Oncology Group Study.
        Blood. 1993; 82: 1086
        • Borowitz M.J.
        • Shuster J.
        • Carroll A.J.
        • et al.
        Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.
        Blood. 1997; 89: 3960
        • Bradstock K.F.
        The diagnostic and prognostic value of immunophenotype in acute leukemia.
        Pathology. 1993; 25: 367
        • Braylan R.C.
        Lymphomas.
        in: Bauer K.D. Duque R.E. Shankey T.V. Clinical Flow Cytometry. Williams and Wilkins, Baltimore1993: 203-234
        • Browman G.P.
        • Neame P.B.
        • Soamboonsrup P.
        The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia.
        Blood. 1986; 68: 900
        • Caldwell C.W.
        • Poje E.
        • Helikson M.A.
        B-cell precursors in normal pediatric bone marrow.
        Am J Clin Pathol. 1991; 95: 816
        • Cossman J.
        • Uppenkamp M.
        T-cell gene rearrangements and the diagnosis of T-cell neoplasms.
        Clin Lab Med. 1988; 8: 31
        • Cuneo A.
        • Michaux J.L.
        • Ferrant A.
        • et al.
        Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers.
        Blood. 1992; 79: 720
        • Davi F.
        • Faili A.
        • Gritti C.
        • et al.
        Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34+ cells.
        Blood. 1997; 90: 4014
        • Denning S.M.
        • Haynes B.F.
        Differentiation of human T cells.
        Clin Lab Med. 1988; 8: 1
        • Drexler H.G.
        • Thiel E.
        • Ludwig W.D.
        Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
        Leukemia. 1991; 5: 637
        • Duque R.E.
        • Everett E.T.
        • Iturraspe J.
        Flow cytometric analysis of acute leukemias.
        Clinical Immunolgy Newsletter. 1990; 10: 43
        • Duque R.E.
        Acute leukemias.
        in: Bauer K.D. Duque R.E. Shankey T.V. Clinical Flow Cytometry. Williams and Wilkens, Baltimore1993: 235-245
        • Fletcher J.A.
        • Lynch E.A.
        • Kimball V.M.
        • et al.
        Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia.
        Blood. 1991; 77: 435
        • Foon K.A.
        • Gale R.P.
        • Todd R.F.
        Recent advances in the immunologic classification of leukemia.
        Semin Hematol. 1986; 23: 257
        • Freedman A.S.
        • Nadler L.M.
        Cell surface markers in hematologic malignancies.
        Semin Oncol. 1987; 14: 193
        • Greaves M.F.
        • Chan L.C.
        • Furley A.J.W.
        • et al.
        Lineage promiscuity in hemopoietic differentiation and leukemia.
        Blood. 1986; 67: 1
        • Greaves M.F.
        A natural history for pediatric acute leukemia.
        Blood. 1993; 82: 1043
        • Harris M.B.
        • Shuster J.J.
        • Carroll A.
        • et al.
        Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A pediatric oncology group study.
        Blood. 1992; 79: 3316
        • Hurwitz C.A.
        • Loken M.R.
        • Graham M.L.
        • et al.
        Asynchronous antigen expression in B lineage acute lymphoblastic leukemia.
        Blood. 1988; 72: 299
        • Izraeli S.
        • Herrn T.
        • Strobl H.
        • et al.
        Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
        Leukemia. 1993; 7: 2054
        • Jennings C.D.
        • Foon K.A.
        Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy.
        Blood. 1997; 90: 2863
        • Kersey J.H.
        Fifty years of studies of the biology and therapy of childhood leukemia.
        Blood. 1997; 90: 4243
        • Kohler G.
        • Milstein C.
        Continuous cultures of fused cells secreting antibody of predefined specificity.
        Nature. 1975; 256: 495
        • Anderson K.C.
        • Bates M.P.
        • Slaughenhoupt B.L.
        • et al.
        Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation.
        Blood. 1984; 63: 1424
        • Little J.V.
        • Foucar K.
        • Duncan M.H.
        • et al.
        A comparative analysis of cytoplasmic mu Cμ) expression in acute lymphoblastic leukemia by molecular and immunologic techniques.
        Am J Clin Pathol. 1992; 97: 885
        • Loken M.R.
        • Shah V.O.
        • Dattilio K.L.
        • et al.
        Flow cytometric analysis of the human bone marrow. II. Normal B-cell development.
        Blood. 1987; 70: 1316
        • Look A.T.
        Oncogenic transcription factors in the human acute leukemias.
        Science. 1997; 278: 1059
        • Melamed M.R.
        • Mullaney P.F.
        • Shapiro H.M.
        An historical review of the development of flow cytometers and sorters.
        in: Melamed M.R. Lindmo T. Mendelsohn M.L. Flow Cytometry and Sorting. Wiley-Liss, Inc, New York1990: 1-9
        • Miller D.R.
        • Leikin S.
        • Albo V.
        • et al.
        Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukemia (ALL).
        Br J Haematol. 1981; 48: 199
        • Mori H.
        • Kiyoi H.
        • Horibe K.
        • et al.
        Comparison of the immunoglobulin gene transcripts between immature B lineage acute lymphoblastic leukemia and the normal phenotypic counterparts in the bone marrow.
        Leukemia. 1997; 11: 1274
        • Nadler L.M.
        • Ritz J.
        • Griffin J.D.
        • et al.
        Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
        Prog Hematol. 1981; 12: 187
        • Nadler L.M.
        B cell/leukemia panel workshop: Summary and comments, in human B lymphocytes.
        in: Reinherz E.L. Haynes B.F. Nadler L.M. Leukocyte Typing II vol 3. Springer-Verlag, New York1986: 1-37
        • Nicholson J.K.
        • Hubbard M.
        • Jones B.M.
        Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry.
        Cytometry. 1996; 26: 16-21
        • Paietta E.
        Proposals for the immunological classification of acute leukemias.
        Leukemia. 1995; 9: 2147
        • Pugh W.C.
        • Stass S.A.
        Immunoglobulin gene rearrangement and its implications for the study of B-cell neoplasia.
        Clin Lab Med. 1988; 8: 45
        • Pui C.H.
        • Behm F.G.
        • Crist W.M.
        Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia.
        Blood. 1993; 82: 343
        • Pui C.H.
        • Frankel L.S.
        • Carroll A.J.
        • et al.
        Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases.
        Blood. 1991; 77: 440
        • Pui C.H.
        • Hancock M.L.
        • Head D.R.
        • et al.
        Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia.
        Blood. 1993; 82: 889
        • Pui C.H.
        • Raimondi S.C.
        • Head D.R.
        • et al.
        Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse.
        Blood. 1991; 78: 1327
        • Pui C.H.
        Acute lymphoblastic leukemia.
        Pediatr Clin North Am. 1997; 44: 831
        • Raimondi S.C.
        Current status of cytogenetic research in childhood acute lymphoblastic leukemia.
        Blood. 1993; 81: 2237
        • Mahin E.J.
        • Riley R.S.
        • Ross W.
        • et al.
        Clinical applications of immunophenotypic analysis.
        in: Riley R.S. Mahn E.J. Ross W. Clinical Applications of Flow Cytometry. IGAKU-SHOIN Medical Publishers, Inc, New York1993: 325-411
        • Roederer M.
        • DeRosa S.
        • Gerstein R.
        • et al.
        8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity.
        Cytometry. 1997; 29: 328
        • Ryan D.H.
        • Chappie C.W.
        • Kossover S.A.
        • et al.
        Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal CALLA-positive B cell precursors.
        Blood. 1987; 70: 814
        • Sang B.C.
        • Shi L.
        • Dias P.
        • et al.
        Monoclonal antibodies specific to the acute lymphoblastic leukemia t(l;19)-associated E2A/pbxl Chimeric Protein: Characterization and diagnostic utility.
        Blood. 1997; 89: 2909
        • Scott C.S.
        • Den Ottolander G.J.
        • Swirsky D.
        • et al.
        Recommended procedures for the classification of acute leukaemias.
        Leuk Lymphoma. 1995; 18: 1
        • Schroff R.W.
        • Foon K.A.
        • Billing R.J.
        • et al.
        Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens.
        Blood. 1982; 59: 207
        • Shapiro H.M.
        Overture. In Practical Flow Cytometry. Alan R. Liss Inc, New York1988
        • Shipp M.A.
        • Look A.T.
        Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!.
        Blood. 1993; 82: 1052
        • Sievers E.L.
        • Lange B.J.
        • Buckley J.D.
        • et al.
        Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.
        J Natl Cancer Inst. 1996; 88: 1483
        • Stass S.
        • Mirro J.
        Unexpected heterogeneity in acute leukemia: Mixed lineages and lineage switch.
        Hum Pathol. 1985; 16: 864
        • Stelzer G.T.
        • Shults K.E.
        • Loken M.R.
        CD45 gating for routine flow cytometric analysis of human bone marrow specimens.
        Ann N Y Acad Sei. 1993; 677: 265
        • Stewart C.C.
        • Behm F.G.
        • Carey J.L.
        • et al.
        U.S.-Canadian Consensus Recommendations on the immunophenotype analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations.
        Cytometry. 1997; 30: 231
        • Thandla S.
        • Apian P.D.
        Molecular biology of acute lymphocytic leukemia.
        Semin Oncol. 1997; 24: 45
        • Trueworthy R.
        • Shuster J.
        • Look T.
        • et al.
        Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group Study.
        J Clin Oncol. 1992; 10: 606
        • Uckun F.M.
        • Gaynon P.
        • Sather H.
        • et al.
        Clinical features and treatment outcome of children with biphenotypic, CD2 + CD19 + acute lymphoblastic leukemia: A Children’s Cancer Group study.
        Blood. 1997; 89: 2488
        • Uckun F.M.
        • Sather H.N.
        • Gaynon P.S.
        • et al.
        Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children’s Cancer Group.
        Blood. 1997; 90: 28
        • Umiel T.
        • Luria D.
        • Stark B.
        • et al.
        Heterogeneity of childhood acute lymphoblastic leukemia (ALL): Monoclonal antibodies phenotyping and induction of differentiation in vitro.
        Leukemia. 1988; 12: 88S
        • Willman C.L.
        • Stewart C.C.
        General principles of multiparameter flow cytometric analysis: Applications of flow cytometry in the diagnostic pathology laboratory.
        Semin Diagn Pathol. 1989; 6: 3
        • Yariv A.
        Some specific laser systems; semiconductor lasers. In Quantum Electronics. John Wiley & Sons, New York1975

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30134-3

      Copyright

      © 1999 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX